68Ga-DOTANOC: Clinical Trials

3 trials of 68Ga-DOTANOC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Unknown 1
Phase 21Terminated 1
Phase 31Terminated 1

Follow 68Ga-DOTANOC: new trials by email Literature Review of 68Ga-DOTANOC trials Research Report on 68Ga-DOTANOC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET-imaging of Unruptured Intracranial Aneurysm Inflammation
PET imaging, 18F-FDG, PET imaging, 68Ga-DOTANOC - Intracranial Aneurysm, Cerebral Aneurysm
Not applicableUnknownTurku University Hospital202021-01-142021-01-20
Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts
FDG ligand, DOTANOC ligand - Tuberculosis, Pulmonary
Phase 1UnknownNational University Hospital, Singapore302016-11-012016-11-18
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
Methionine, DOTANOC - Pulmonary Sarcoidosis
Phase 2 / Phase 3TerminatedTurku University Hospital52016-05-012026-10-07

Conditions studied

Inflammation (1)  ·  Intracranial Aneurysm (1)  ·  Sarcoidosis, Pulmonary (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Turku University Hospital (2)  ·  National University Hospital, Singapore (1)

Countries

Finland (2)  ·  Singapore (1)

Top investigators

Antti Saraste, MD, Prof. (1)  ·  Jaakko Rinne, MD, Prof. (1)  ·  Juhani Knuuti, MD, PhD (1)  ·  Nicholas Paton (1)

Results publications

PMID 38382960